Seattle Genetics Says Adcetris Sets New Standard In Frontline Lymphoma
• By Emily Hayes
Seattle Genetics' antibody drug conjugate Adcetris combines an antibody and cytotoxic payload of monomethyl auristatin E (depicted above) targeted at CD30 on lymphoma cells.
Keep up with the top pharma business news of the week. On the go.
